STRIVE Post-Market Registry Study
STRIVE Post-Market Registry Study
Recruiting · NCT04302272 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| STRIVE Post-Market Registry Study | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder | Recruiting | Not stated | 2026-08-03 | NCT04302272 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Olympus Corporation of the Americas | 5 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AnMed Health | Anderson | United States | 15 |
| Baylor Scott & White Research Institute | Dallas | United States | 15 |
| Beth Israel Decaconess | Boston | United States | 1 |
| Dignity Health St. Joseph's Hospital and Medical Center | Phoenix | United States | 1 |
| Duke University Medical Center | Durham | United States | 505 |
| El Camino, Taft Center for Clinical Research | Mountain View | United States | 1 |
| LSU Health Shreveport | Shreveport | United States | 2 |
| Memorial Hospital at Gulfport | Gulfport | United States | 3 |
| Northwestern University, Division of Pulmonary and Critical Care Medicine | Chicago | United States | 1 |
| Penn State Milton S. Hershey Medical Center | Hershey | United States | 44 |
| Temple University | Philadelphia | United States | 50 |
| University of Chicago | Chicago | United States | 312 |
| University of Maryland | Baltimore | United States | 86 |
| University of Miami | Coral Gables | United States | 34 |
| University of Texas Health Science Center at Houston | Houston | United States | 42 |
| University of Texas Southwestern | Dallas | United States | 73 |